Continuing coverage

New daily diabetes pill that helps with weight loss launches in UK pharmacies

The launch of Orforglipron (Foundayo), a daily weight loss pill developed by Eli Lilly, in UK pharmacies, prompting warnings about counterfeit products and highlighting the need for safe distribution of new health treatments.

First tracked August 25, 2026 at 12:39 PM CDT · Latest material update August 25, 2026 at 12:40 PM CDT

August 25, 2026 at 12:40 PM CDT

New Weight Loss Pill Launches in UK Pharmacies Amid Counterfeit Fears

A new daily diabetes pill that helps with weight loss has launched in UK pharmacies, offering an oral treatment option for eligible patients. This development sparks a conversation about the intersection of pharmaceutical innovation, regulatory oversight, and consumer safety in the rapidly evolving wellness market.